Submitted by Anonymous (not verified) on 24 June 2026 - 15:50
Human medicines European public assessment report (EPAR): Tecvayli, teclistamab, Date of authorisation: 23/08/2022, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tecvayli, teclistamab, Date of authorisation: 23/08/2022, Revision: 8, Status: Authorised